Authors:
Parlato, S
Santini, SM
Lapenta, C
Di Pucchio, T
Logozzi, M
Spada, M
Glammarioli, AM
Malorni, W
Fais, S
Belardelli, F
Citation: S. Parlato et al., Expression of CCR-7, MIP-3 beta, and Th-1 chemokines in type IIFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities, BLOOD, 98(10), 2001, pp. 3022-3029
Authors:
Parlato, S
Santini, SM
Lapenta, C
Spada, M
Logozzi, M
Rizza, P
Proietti, E
Belardelli, F
Fais, S
Citation: S. Parlato et al., Primary HIV-1 infection of human CD4+T cells passaged into SCID mice leadsto selection of chronically infected cells through a massive Fas-mediated autocrine suicide of uninfected cells, CELL DEAT D, 7(1), 2000, pp. 37-47
Authors:
Mecchia, M
Matarrese, P
Malorni, W
D'Agostino, G
Sestili, P
Santini, SM
Gauzzi, MC
Venditti, M
Mazzocchi, A
Parmiani, G
Belardelli, F
Ferrantini, M
Citation: M. Mecchia et al., Type I consensus interferon (CIFN) gene transfer into human melanoma cellsup-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha, GENE THER, 7(2), 2000, pp. 167-179
Authors:
Santini, SM
Lapenta, C
Logozzi, M
Parlato, S
Spada, M
Di Pucchio, T
Belardelli, F
Citation: Sm. Santini et al., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice, J EXP MED, 191(10), 2000, pp. 1777-1788
Authors:
Schiavoni, G
Mattei, F
Di Pucchio, T
Santini, SM
Bracci, L
Belardelli, F
Proietti, E
Citation: G. Schiavoni et al., Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer, BLOOD, 95(6), 2000, pp. 2024-2030
Authors:
Rozera, C
Mecchia, M
Gresser, I
Bandu, MT
Proietti, E
Venditti, M
Sestili, P
Santini, SM
Fais, S
Belardelli, F
Ferrantini, M
Citation: C. Rozera et al., Murine interferon-alpha(1) gene-transduced ESb tumor cells are rejected byhost-mediated mechanisms despite resistance of the parental tumor to interferon-alpha/beta therapy, CANC GENE T, 6(3), 1999, pp. 246-253
Authors:
Lapenta, C
Santini, SM
Proietti, E
Rizza, P
Logozzi, M
Spada, M
Parlato, S
Fais, S
Pitha, PM
Belardelli, F
Citation: C. Lapenta et al., Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells, VIROLOGY, 263(1), 1999, pp. 78-88
Authors:
Fais, S
Lapenta, C
Santini, SM
Spada, M
Parlato, S
Logozzi, M
Rizza, P
Belardelli, F
Citation: S. Fais et al., Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation differentiation of human target cells at the time of primary infection, J VIROLOGY, 73(8), 1999, pp. 6453-6459
Authors:
Lapenta, C
Boirivant, M
Marini, M
Santini, SM
Logozzi, M
Viora, M
Belardelli, F
Fais, S
Citation: C. Lapenta et al., Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection, EUR J IMMUN, 29(4), 1999, pp. 1202-1208
Authors:
Belardelli, F
Ferrantini, M
Santini, SM
Baccarini, S
Proietti, E
Colombo, MP
Sprent, J
Tough, DF
Citation: F. Belardelli et al., The induction of in vivo proliferation of long-lived CD44(hi) CD8(+) T cells after the injection of tumor cells expressing IFN-alpha(1) into syngeneic mice, CANCER RES, 58(24), 1998, pp. 5795-5802